Efficacy and safety of birch pollen allergoid subcutaneous immunotherapy: A 2‐year double‐blind, placebo‐controlled, randomized trial plus 1‐year open‐label extension-Reference-Cited by-同舟云学术

Efficacy and safety of birch pollen allergoid subcutaneous immunotherapy: A 2‐year double‐blind, placebo‐controlled, randomized trial plus 1‐year open‐label extension

Published:2019-02-27 Issue:4 Volume:49 Page:516-525
ISSN:0954-7894
Container-title:Clinical & Experimental Allergy
language:en
Short-container-title:Clin Exp Allergy

Author:

Worm Margitta¹^ORCID,Rak Sabina²,Samoliński Boleslaw³,Antila Jukka⁴,Höiby Ann‐Sofi²,Kruse Brigitte⁵,Lipiec Agnieszka³,Rudert Michael⁵,Valovirta Erkka⁶⁷

Affiliation:

1. Division of Allergy and Immunology Department of Dermatology Allergy and Venerology Charité Universitätsmedizin Berlin Berlin Germany

2. Asthma and Allergy Research Group Department of Respiratory Medicine and Allergology Sahlgrenska University Hospital Gothenburg Sweden

3. Department of the Prevention of Environmental Hazards and Allergology Medical University of Warsaw Warsaw Poland

4. Ear, Nose and Throat Clinic Terveystalo Hospital Turku Finland

5. Allergopharma GmbH & Co. KG Reinbek Germany

6. Department of Lung Diseases and Clinical Allergology University of Turku TurkuFinland

7. Allergy Clinic Terveystalo Hospital Turku Finland

Funder

Allergopharma GmbH & Co. KG

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cea.13331

Reference40 articles.

1. World Health Organization (WHO).Phenology and Human Health: Allergic Disorders.2003; Report No.: EUR/031S036791 ‐ E79129.

2. A method to derive vegetation distribution maps for pollen dispersion models using birch as an example

3. SiljamoP.Numerical modelling of birch pollen emissions and dispersion on regional and continental scales.Finnish Meteorological Institute Contributions 99 (FMI‐CONT‐99). September 2013.

4. Sustained efficacy and safety of a 300IR daily dose of a sublingual solution of birch pollen allergen extract in adults with allergic rhinoconjunctivitis: results of a double‐blind, placebo‐controlled study

5. Sources, impact and exchange of early-spring birch pollen in the Moscow region and Finland

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Focused allergic rhinitis practice parameter for Canada;Allergy, Asthma & Clinical Immunology;2024-08-08

2. The combination of allergen immunotherapy and biologics for inhalant allergies: Exploring the synergy;Annals of Allergy, Asthma & Immunology;2024-06

3. Investigating Experimental Treatments for Rhinitis: A State-of-the-Art Systematic Review;Ear, Nose & Throat Journal;2024-01-11

4. A high‐dose, depigmented polymerized birch pollen extract for subcutaneous allergen immunotherapy has a favourable efficacy/safety ratio;Clinical and Translational Allergy;2023-11

5. Pharmacotherapy and immunotherapy of allergic rhinitis induced by house dust mite, grass, and birch pollen allergens: a meta-analysis of randomized clinical trials;Expert Review of Respiratory Medicine;2023-07-03